4//SEC Filing
Nuyten Dimitry SA 4
Accession 0001209191-22-047316
CIK 0001724521other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 4:08 PM ET
Size
7.1 KB
Accession
0001209191-22-047316
Insider Transaction Report
Form 4
Nuyten Dimitry SA
Chief Medical Officer
Transactions
- Award
Common Stock
2022-08-23+42,500→ 42,500 total - Award
Stock Option (Right to Buy)
2022-08-23+170,000→ 170,000 totalExercise: $26.00Exp: 2032-08-22→ Common Stock (170,000 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in four equal annual installments beginning September 15, 2023, subject to the Reporting Person's continued service to the Company.
- [F2]The option is exercisable in 48 equal monthly installments after August 1, 2022, subject to the Reporting Person's continued service to the Company.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001776564
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 4:08 PM ET
- Size
- 7.1 KB